Heron Therapeutics (HRTX) Net Equity Issued and Repurchased (2009 - 2026)
Heron Therapeutics' Net Equity Issued and Repurchased came in at -$1.53 million for Q4 2025, compared with $462,000 a year earlier.
Powered by 
Analysis
Heron Therapeutics (HRTX) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For FY2025, Heron Therapeutics' Net Equity Issued and Repurchased was $18.31 million.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 22.1% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $637,000 in FY2024 (-97.9%), $29.76 million in FY2023 (-60.4%), $75.15 million in FY2022 and $2.14 million in FY2021 (-68.4%).
- The Q4 2025 figure represents the lowest quarterly Net Equity Issued and Repurchased since Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Heron Therapeutics | 70.40 Mn | -87.13 Mn | 26.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 276,000.00 |
| Mar 31, 2026 | -51,000.00 |
| Dec 31, 2025 | -1.27 Mn |
| Sep 30, 2025 | 19.84 Mn |
| Jun 30, 2025 | 523,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Dec 31, 2024 | 462,000.00 |
| Jun 30, 2024 | 164,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 201,000.00 |
| Sep 30, 2023 | 29.76 Mn |
| Jun 30, 2023 | 912,000.00 |
| Mar 31, 2023 | -208,000.00 |
| Dec 31, 2022 | 654,000.00 |
| Sep 30, 2022 | 75.16 Mn |
| Jun 30, 2022 | 1.41 Mn |
| Mar 31, 2022 | -637,000.00 |
| Dec 31, 2021 | 610,000.00 |
| Jun 30, 2021 | 646,000.00 |
| Mar 31, 2021 | 883,000.00 |
API Access
Heron Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();